about
Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerQuantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains.Creation, validation, and quantitative analysis of protein expression in vascular tissue microarrays.Multiplexed ion beam imaging of human breast tumorsQuantitative measurement of cancer tissue biomarkers in the lab and in the clinic.Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades.Immunohistochemistry and mass spectrometry for highly multiplexed cellular molecular imaging.Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoringObjective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance.Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancerSemi-Automated Digital Image Analysis of Pick's Disease and TDP-43 Proteinopathy.Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy.Use of human vascular tissue microarrays for measurement of advanced glycation endproductsValidation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness.Multiplexed ion beam imaging analysis for quantitation of protein expresssion in cancer tissue sections.Phenotyping Multiple Subsets of Immune Cells In Situ in FFPE Tissue Sections: An Overview of Methodologies.Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization.Quantitative analysis of p53 expression in human normal and cancer tissue microarray with global normalization method.Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease.Antibodies are forever: a study using 12-26-year-old expired antibodies.Engineering and physical sciences in oncology: challenges and opportunities.Ductal cells of minor salivary glands in Sjögren's syndrome express LINE-1 ORF2p and APOBEC3B.Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections.A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2.Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes
P2860
Q26778586-0081457E-9F4D-4CD9-9360-BF8A3394E083Q27302276-D5473C34-0391-4578-A997-20F88854B972Q33343565-E569ECA5-5025-46FD-B564-6B48D60E31ACQ33529063-DC45B723-878E-4030-8119-66E746A4CD81Q33838256-B42FBE1B-BB86-4521-BAEB-D12A6BCDB4ADQ33949706-231675A6-67E5-48C0-9775-28CA8B3D34A9Q35251561-8C5B81C5-64BF-471B-9357-7F864AD7D98BQ35440615-6E0D467E-51B8-456A-BF54-3B04B4BCBAD2Q35570005-800A2DDE-997F-4291-B870-D2508FC54F04Q36009610-D3129E1F-99FB-402F-90DC-F350F3DA4CA8Q36048767-F1291EFC-1EEB-495D-B390-E560D60866AAQ36280470-97CFB5A5-50B5-4262-AB57-7F442E46CF9BQ36559818-C0364769-BB8C-4164-9040-212B87FBC1D2Q36737104-0FD3801F-467F-4465-85C5-54D498BF5ABFQ37031799-D2676346-7F3C-45CC-9E36-FD9CCA0A2726Q37142882-7BCBFAB6-AEF5-4DFD-87F2-77125314F1DFQ37212344-3778F35E-359D-42B0-8977-E61044B15CE1Q37306543-BABAADC0-E023-4DAE-B1EB-98E63C7484B4Q37379373-C7413E3D-A311-4EA3-AECA-B18E594AC14DQ37461802-83EC8833-E906-4530-B7D3-E773A0D10266Q37563863-8A8D0B8F-CF65-4A07-9E97-59C1D204DC07Q37604397-1D084C77-7F0F-4A3A-963D-9740FB316776Q37658459-F6A3BC0A-B50B-401D-870D-F6E9174E048AQ37706890-E6DC0C85-FE4B-4364-AC08-F053693A453DQ38373772-D0EF07AA-42EE-4EBC-9A67-E007AF3B26BDQ38633233-DCE2ED22-8E37-4463-A66A-5EEFC82D45F3Q38758647-D5E19FF7-C7C7-4346-B976-EA6F87945D5EQ39023269-1C16104F-1850-4034-B0A3-216E7925FA6CQ39368513-65DADF17-334C-420B-BB27-3A31330D3E01Q39990401-369545C9-5B96-4C46-9D5F-9EC9E388D0E5Q40217601-FB0DF993-A686-4085-974F-F9882F22D5D2Q45028553-57D6F975-106A-4CDF-B241-7F9FC2520913Q45072555-A09ABEC9-B42D-4BA9-AD82-185289BD877DQ47244877-8CFAF8A5-4651-47A1-9D74-4A6A85337940Q47618684-AE2B7320-A7EC-487F-8299-43DCB7ADDDF1Q50899679-DAE4960A-416F-4B7F-9285-E7AB93D88910Q51371303-85DA376C-94E3-4BE0-B761-ED0E04470DDCQ52659649-9C51348F-051A-4ED1-B60D-F19E03BB3AA4Q56395210-7961833C-9074-4D6A-B343-96A413E00EDF
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
What brown cannot do for you.
@ast
What brown cannot do for you.
@en
type
label
What brown cannot do for you.
@ast
What brown cannot do for you.
@en
prefLabel
What brown cannot do for you.
@ast
What brown cannot do for you.
@en
P2860
P356
P1433
P1476
What brown cannot do for you.
@en
P2093
David L Rimm
P2860
P2888
P304
P356
10.1038/NBT0806-914
P577
2006-08-01T00:00:00Z